10x Genomics (TXG) Enterprise Value (2018 - 2025)
Historic Enterprise Value for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to -$523.4 million.
- 10x Genomics' Enterprise Value fell 3304.69% to -$523.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$523.4 million, marking a year-over-year decrease of 3304.69%. This contributed to the annual value of -$523.4 million for FY2025, which is 3304.69% down from last year.
- As of Q4 2025, 10x Genomics' Enterprise Value stood at -$523.4 million, which was down 3304.69% from -$482.1 million recorded in Q3 2025.
- 10x Genomics' Enterprise Value's 5-year high stood at -$356.9 million during Q3 2023, with a 5-year trough of -$640.1 million in Q2 2021.
- Over the past 5 years, 10x Genomics' median Enterprise Value value was -$438.6 million (recorded in 2022), while the average stood at -$468.2 million.
- Over the last 5 years, 10x Genomics' Enterprise Value had its largest YoY gain of 2749.93% in 2021, and its largest YoY loss of 7059.91% in 2021.
- Quarter analysis of 5 years shows 10x Genomics' Enterprise Value stood at -$588.5 million in 2021, then increased by 26.93% to -$430.0 million in 2022, then increased by 9.6% to -$388.7 million in 2023, then decreased by 1.21% to -$393.4 million in 2024, then crashed by 33.05% to -$523.4 million in 2025.
- Its last three reported values are -$523.4 million in Q4 2025, -$482.1 million for Q3 2025, and -$447.3 million during Q2 2025.